HB 797 prohibits employers from discriminating against fire and rescue public safety employees who use medical cannabis, provided they have a valid written certification from a licensed healthcare provider under Maryland's medical cannabis program. The bill modifies existing law to clarify that an employer cannot take adverse employment actions (like termination or denial of promotion) solely due to medical cannabis use, as long as the employee meets the state's certification requirements. It updates definitions in Maryland law to ensure fire and rescue employees qualify for the same protections as other medical cannabis patients under the existing program. The law does not override workplace safety rules or require employers to accommodate cannabis use during work hours.
SB 866 requires chain restaurants with 20 or more locations in Maryland to display warning icons next to menu items exceeding 1,150mg sodium or 25mg added sugars per serving, starting January 1, 2028. The Maryland Department of Health must create these icons and guidelines by January 1, 2027, and run a public education campaign during 2027 to explain compliance. The bill directly affects large chain restaurants by mandating clear labeling of high-sodium and high-sugar menu items. It defines "high sodium" as 1,150mg per serving and "high added sugars" as 25mg per serving for labeling purposes.
HB 494 requires health insurance companies, nonprofit health service plans, and health maintenance organizations (HMOs) operating in Maryland to structure their reimbursements to primary care providers in a way that meets annual investment targets set by the state. Starting February 1, 2026, these entities must report their progress toward meeting these targets when filing new or updated premium rates with the Maryland Insurance Commissioner. The bill amends insurance code sections to mandate this reporting requirement as part of premium rate filings. It takes effect October 1, 2026, focusing on transparency and accountability for primary care funding.
HB 598 creates a temporary license for internationally trained physicians to practice medicine in Maryland under specific conditions. It allows the State Board of Physicians to issue a 3-year license (non-renewable) to doctors who hold a WHO-recognized medical degree outside the U.S., completed 2 years of equivalent postgraduate training, practiced medicine for 5 of the last 7 years abroad, passed U.S. medical exams (USMLE Steps 1-3), and meet other criteria like English proficiency and Maryland residency. The license requires physicians to pursue full licensure through board-established pathways after the temporary period ends. This directly affects internationally trained doctors seeking to work in Maryland’s healthcare system, providing a structured but limited pathway to practice.
HB 813 authorizes Maryland's Medicaid program (Maryland Medical Assistance Program) to cover comprehensive obesity treatment, including intensive behavioral therapy, bariatric surgery, and FDA-approved weight management medications, starting January 1, 2027. The bill requires the Maryland Department of Health to notify Medicaid recipients if it chooses to provide this coverage and mandates a report to the legislature by November 1, 2027, on implementation progress. This directly affects Medicaid recipients with obesity by expanding covered treatments beyond current scope. The program may use standard utilization management processes (like for other conditions) to assess medical necessity but is not required to offer the coverage.
This bill updates Maryland's newborn screening program by changing how fees are set and how new tests are added to the screening panel. It requires the Department of Health to charge fees that cover all administrative, laboratory, and follow-up costs rather than setting a specific maximum amount. The bill also establishes a process where an advisory council must review risks, costs, and accessibility before the department decides whether to test for new conditions added to the national screening panel. Additionally, it extends the timeline for implementing new tests to two years if equipment or supplies are delayed, with required reporting to state committees.
HB 921 limits when minors in Maryland juvenile facilities can be placed in restrictive housing (isolation or special confinement). It prohibits using restrictive housing for discipline, punishment, or staff convenience, and requires facilities to use it only for immediate safety risks (like harm to self/others or facility security) for the shortest time possible (max 6 hours). Minors can request restrictive housing or withdraw that request at any time, and facilities must provide mental health screenings within 1 hour of placement. The bill also mandates that minors in restrictive housing receive the same access to phone calls, visits, medical care, education, and recreation as other minors, unless safety is at risk.
HB 1617 establishes "Health Innovation Zones" in Maryland counties to address health disparities. It defines zones as areas with documented health gaps (like high maternal complications, chronic diseases, or low access to care) in communities of color, low-income areas, or immigrant populations. Counties must create incentives for grocery stores, pharmacies, and healthcare providers to locate in these zones, and Prince George’s County must designate specific zones (including the Blue Line Corridor and areas near DC) while seeking additional zones meeting the same criteria. The bill requires annual $5 million state funding starting in 2028 for the Maryland Economic Development Corporation to support these businesses and exempts them from local zoning laws within designated zones.
HB 883 prohibits AI developers from making or causing AI to make claims that the AI is a behavioral health provider or can deliver behavioral health care services. It requires AI sold to Maryland consumers to include clear notices stating users are interacting with AI (not a human) and to detect suicidal thoughts or self-harm, automatically referring users to crisis services. Violations carry civil penalties up to $1 million per offense, with funds directed to Maryland’s Behavioral Health Workgroup Investment Fund. The law directly affects AI developers and sellers operating in Maryland, focusing on preventing misleading AI interactions in mental health contexts.
HB 1143 bans the use of the "lung float test" (a hydrostatic lung test) during perinatal autopsies in Maryland. It directly affects the Chief Medical Examiner, deputy examiners, assistant examiners, and authorized pathologists when determining if a death was a stillbirth or occurred after a live birth. The bill prohibits this specific test method and allows parents, guardians, or legal representatives to file a civil lawsuit if the test is used unlawfully. Violations also become grounds for disciplinary action against medical examiners.
